Literature DB >> 22495365

Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases.

Ankur R Sangoi1, Jesse K McKenney, James D Brooks, Joseph V Bonventre, John P Higgins.   

Abstract

In a subset of cases, metastatic renal cell carcinoma can demonstrate significant morphologic overlap with germ cell neoplasms, making accurate diagnosis challenging. In such cases, immunohistochemistry is often used as an adjunct diagnostic tool. Expression of the putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 has been reported in a small series of certain germ cell tumors, raising doubt about their specificity for renal cell carcinoma. To further characterize these markers, we evaluated PAX-2, PAX-8, and hKIM-1 staining in 100 germ cell tumors using tissue microarrays. PAX-2 and PAX-8 staining was identified in 50% and 25% of yolk sac tumors (respectively), with hKIM-1 staining identified in 48% of embryonal carcinomas and 50% of yolk sac tumors. All other germ tumor cells (notably including 62 seminomas) were negative for all 3 markers, in contrast to prior reports of PAX-8 reactivity in seminoma. This study indicates that PAX-2, PAX-8, and hKIM-1 should be used cautiously in distinguishing renal cell carcinoma from nonseminomatous germ cell neoplasia and also adds to the growing list of nonrenal tumors that express these 3 markers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495365      PMCID: PMC4077160          DOI: 10.1097/PAI.0b013e31824bb404

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  23 in total

1.  Metastatic tumor of the spermatic cord from renal cell carcinoma.

Authors:  K Gohji; T Nakanishi; K Yoshimura; S Kamidono
Journal:  Hinyokika Kiyo       Date:  1990-07

2.  PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.

Authors:  Guo-Xia Tong; Lorenzo Memeo; Cristina Colarossi; Diane Hamele-Bena; Cristina Magi-Galluzzi; Ming Zhou; Stephen M Lagana; Lara Harik; Jennifer M Oliver-Krasinski; Mahesh Mansukhani; Lorenzo Falcone; Hanina Hibshoosh; Kathleen O'Toole
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

3.  Testicular tumor as the first manifestation of renal carcinoma.

Authors:  A Talerman; W F Kniestedt
Journal:  J Urol       Date:  1974-05       Impact factor: 7.450

4.  Renal cell carcinoma metastatic to the testis and its adnexa: a report of five cases including three that accounted for the initial clinical presentation.

Authors:  M W Datta; T M Ulbright; R H Young
Journal:  Int J Surg Pathol       Date:  2001-01       Impact factor: 1.271

5.  Metastasis to the funiculus spermaticus as the first sign of renal cell carcinoma.

Authors:  B Marković; M Oprić; V Prica; V Colović; R Mandić; A Jeremić
Journal:  World J Surg       Date:  1983-09       Impact factor: 3.352

6.  Renal cell carcinoma involving penis and testis: unusual initial presentations of metastatic disease.

Authors:  G F Daniels; A J Schaeffer
Journal:  Urology       Date:  1991-04       Impact factor: 2.649

Review 7.  A right-sided renal carcinoma uniquely presenting as a mass in the spermatic cord.

Authors:  J A Hicks; J P Britton; P G Carter; B Conroy
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

8.  Metachronous renal cell carcinoma metastases to spermatic cord and penis.

Authors:  M L Fallick; J P Long; A Ucci
Journal:  Scand J Urol Nephrol       Date:  1997-06

9.  Tumours of the male urogenital tract: a clinicopathologic study.

Authors:  S Sharma; P Nath; A N Srivastava; K M Singh
Journal:  J Indian Med Assoc       Date:  1994-11

10.  Tumours of the spermatic cord and paratesticular tissue. A clinicopathological study.

Authors:  T F Lioe; J D Biggart
Journal:  Br J Urol       Date:  1993-05
View more
  1 in total

Review 1.  Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review).

Authors:  Т А Karmakova; N S Sergeeva; К Yu Kanukoev; B Ya Alekseev; А D Kaprin
Journal:  Sovrem Tekhnologii Med       Date:  2021-06-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.